Seres Therapeutics (Germany) Today
| 1S9 Stock | EUR 0.84 0.01 1.20% |
Performance2 of 100
| Odds Of DistressLess than 27
|
Seres Therapeutics is trading at 0.84 as of the 12th of December 2024. This is a 1.20 percent increase since the beginning of the trading day. The stock's lowest day price was 0.84. Seres Therapeutics has about a 27 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 13th of October 2024 and ending today, the 12th of December 2024. Click here to learn more.
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. The company has 124.59 M outstanding shares. More on Seres Therapeutics
Moving against Seres Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Seres Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Seres Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Seres Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Eric Shaff |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Seres Therapeutics (1S9) is traded on Frankfurt Exchange in Germany and employs 333 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 608.32 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Seres Therapeutics's market, we take the total number of its shares issued and multiply it by Seres Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Seres Therapeutics classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 124.59 M outstanding shares.
Seres Therapeutics has accumulated about 253.62 M in cash with 6.69 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Seres Therapeutics Probability Of Bankruptcy
Ownership AllocationSeres Therapeutics shows a total of 124.59 Million outstanding shares. The majority of Seres Therapeutics outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Seres Therapeutics to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Seres Therapeutics. Please pay attention to any change in the institutional holdings of Seres Therapeutics as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Seres Ownership Details
Seres Therapeutics Risk Profiles
Although Seres Therapeutics' alpha and beta are two of the key measurements used to evaluate Seres Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.6 | |||
| Semi Deviation | 6.35 | |||
| Standard Deviation | 7.98 | |||
| Variance | 63.75 |
Seres Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Seres Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Seres Therapeutics Corporate Directors
| Dennis Ausiello | Independent Director | Profile | |
| Willard Dere | Independent Director | Profile | |
| Richard Kender | Independent Director | Profile | |
| Meryl Zausner | Independent Director | Profile |
Additional Information and Resources on Investing in Seres Stock
When determining whether Seres Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Seres Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Seres Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Seres Therapeutics Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Seres Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Seres Stock please use our How to Invest in Seres Therapeutics guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .